Mumbai outpaced Bangalore, with a margin of about Rs 200 crore, to become India's top biotech city in terms of revenue.

In an interview with ET Now, Kiran Mazumdar Shaw, Chairperson & Managing Director, Biocon, talks about the biosimilars market.